Nuvectis Pharma, Inc.NVCTNASDAQ
Loading
ROE: Returns DecliningContracting
Percentile Rank40
Studio
Year-over-Year Change

Return on equity

Percentile
P40
Within normal range
vs 5Y Ago
-1.4x
Contraction
Streak
1 yr
Consecutive growthContracting
PeriodValueYoY Change
2025-143.61%+26.6%
2024-195.61%-7.2%
2023-182.44%-35.9%
2022-134.22%-214.6%
2021117.10%+17.1%
2020100.00%-